Inhibikase Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/08/2026 | Sep 2025Filed 14/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/08/2026 | Sep 2024Filed 14/11/2025 | Jun 2024Filed 14/11/2025 | Mar 2024Filed 14/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| −$20 | −$16 | −$12 | −$9.9 | −$14 | −$5.8 | −$5 | −$4.6 | |
| −$0.11 | −$0.10 | −$0.13 | −$0.11 | −$0.15 | −$0.65 | −$0.66 | −$0.73 | |
| 175 | 172 | 90 | 90 | 90 | 8.9 | 7.5 | 6.3 |
Trend